Glenmark meets endpoint at Phase 3 safety study evaluating Ryaltris in patients with rhinitis
Ryaltris has been conditionally accepted as the brand name for GSP 301 Nasal Spray by the US FDA
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
SCHOTT KAISHA announces path breaking innovation in pharma packaging
Announces the opening of a second production module at its manufacturing plant in Jambusar, Gujarat
ISCR’s 4th National Pharmacovigilance Symposium held in Hyderabad
The Theme of the event was Enhancing Pharmacovigilance Excellence in India: An Integrated Approach
Orchid Pharma gets US FDA approval for schizophrenia drug
The tablets are atypical antipsychotic, indicated in the treatment of symptoms related to psychotic conditions
J B Chemicals & Pharma gets US FDA nod for hypertension tablets
US FDA approved supplementary ANDA for Atenolol tablets USP 25mg, 50mg and 100 mg
Novartis’ Scapho shows pioneering 4-year data in preventing Ankylosing Spondylitis progression
These new data also confirm sustained improvement in signs and symptoms in almost 80 percent of patients, with a favourable and…
Suven Life secures product patents in India and US
The patents are valid through 2029 and 2033 respectively
Torrent, Novo Nordisk India expand insulin manufacturing facility at Indrad
Through the partnership, both the companies will continue to ensure the provision of cost-effective yet high-quality medication
Rhizen receives US FDA approval
The company has received fast track designation for its cancer drug
Curadev in research partnership with UT Southwestern Medical Center
The partnership will help identify small molecule drugs for the treatment of specific cancers